In this issue of Johns Hopkins Urology, our cover story features a multicenter trial, led by Christian Pavlovich, of high-resolution ultrasound, which has outperformed conventional transrectal ultrasound in detecting prostate cancer. In a related story is cutting-edge research by Ted Schaeffer showing that African-American men have a one-third chance of having more aggressive cancer than the biopsy suggests.
Johns Hopkins has been a world referral center for bladder exstrophy for nearly four decades. Now Heather Di Carlo is pioneering a new way to approach exstrophy closure using MRI-guided navigation of the pelvic floor.
Our multidisciplinary Men’s Health and Vitality Program, led by Kevin Billups, doesn’t just treat erectile dysfunction and low testosterone, but allows us to address the underlying causes and help the whole patient.
And finally, a new urine test developed at Johns Hopkins may soon help detect bladder cancer, pick up recurrent cancer and separate aggressive tumors from indolent cancers. This is part of the momentum generated by our new Greenberg Bladder Cancer Institute and part of our overall multifaceted, multidisciplinary approach to all of urology.